Navigation Links
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
Date:5/15/2012

same platinum chromium alloy and similar design used in the PROMUS Element Stent with a novel coating created to significantly reduce the amount of polymer and drug to which the blood vessel wall is exposed, without compromising inhibition of neointimal growth," said Keith D. Dawkins, M.D., global chief medical officer for Boston Scientific.  "SYNERGY is designed to address potential limitations with durable polymer coatings used on currently available drug-eluting stents, including issues with dual antiplatelet therapy interruption and duration. We continue to be pleased with the impressive clinical and angiographic results from the EVOLVE trial for this advanced coronary stent technology."

EVOLVE trial data are expected to support CE Mark approval for the SYNERGY Stent, which is expected as early as later this year, while additional larger studies are anticipated to further assess clinical event rates and the potential for reduced dual antiplatelet therapy with this novel stent technology. 

The SYNERGY Stent is an investigational device, limited by applicable law to investigational use only and not available for sale. 

About the SYNERGY Stent

The SYNERGY Stent uses a bioabsorbable PLGA polymer and everolimus drug combination to create an ultra-thin, uniform coating applied to the outer (abluminal) surface of the stent.  After the drug has been delivered, the bioabsorbable coating is designed to absorb within four months of implantation, leaving only a bare-metal PtCr stent.  This technology is designed to provide the same degree of restenosis reduction as a conventional drug-eluting stent while offering faster and more complete vessel healing after stent implantation, which could potentially reduce the duration or allow safer interruption of post-procedure dual antiplatelet therapy.  The SYNERGY Stent features the same proprietary platinum chromium alloy and similar stent design used in the PROMUS
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
2. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
4. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
5. New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohns Disease
6. Diabetes Conversation Map(TM) Education Tools Celebrate One-Year Anniversary
7. ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Treating Patients with Crohns Disease at the United European Gastroenterology Federation (UEGW) Meeting
8. One-Year European Registry Data Released for Popliteal Stenting With SUPERA®
9. Former NxStage System One User Celebrates One-Year Kidney Transplant Anniversary
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Elekta VMAT Radiation Therapy Rapidly Gaining Users Worldwide as Technique Evolves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , September 4, 2015 ... announces that Hutchison MediPharma Limited ("HMP"), its drug ... the second proof-of-concept ("POC") trial of fruquintinib in ... ("NSCLC") in China .  The ... in meeting the primary efficacy endpoint of progression ...
(Date:9/3/2015)... , Sept. 3, 2015 ... of New Drugs, Industry Changes and Emerging Opportunities ... human ovaries? Visiongain,s new study forecasts those pharmaceutical ... in that industry. You also explore trends, results, ... Our report gives revenue predictions to 2025 at ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... – Your New Guide to that Market, its R&D and ... want to assess the future of cancer-treating medicines? Visiongain,s new ... helping you stay ahead. There you discover financial data, R&D ... In our analysis you see forecasted sales ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7
... Vary in Their Prescribing Patterns of Levodopa/Carbidopa and Dopamine ... Mass., March 4 Decision Resources, one of the ... and healthcare issues, finds that second-line patient share of ... to 35.2 percent since last year,s report. Most of ...
... in Small, Ambulatory Physician PracticesSCHAUMBURG, Ill., March 3 ... Information Technology (CCHIT(R)), the federally recognized body for ... announced it will develop dermatology-specific functionality criteria beginning ... a response to an application from the American ...
Cached Medicine Technology:Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease 2Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease 3Certification Commission for Healthcare Information Technology to Develop Dermatology-Specific Functionality Criteria for Electronic Health Record (EHR) Technology 2
(Date:9/4/2015)... ... , ... According to an article published September 1 by the ... and assisted living facilities are receiving insufficient care that could actually be shortening their ... at one point close to death, not because of a medical condition, but because ...
(Date:9/4/2015)... ... September 04, 2015 , ... With TransCel from Pixel Film Studios users can ... Pro X. With TransCel users have full control over camera position and angle within ... frame color, inner color, text, and more. With TransCel the possibilities are endless. , ...
(Date:9/4/2015)... ... 2015 , ... IVF New England, one of the largest and most successful ... in Manchester for women who wish to learn more about their fertility and egg ... lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , This hip, casual ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County charitable organization ... Compassion Project is a non-profit organization dedicated to offering Pilates scholarships to cancer ... treatments and recover their mobility, strength, and range of motion following breast cancer ...
(Date:9/4/2015)... ... 2015 , ... “Getting away from the daily stressors and distractions of life ... their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort Maui ... only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in Hawaii, ...
Breaking Medicine News(10 mins):Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3
... York: It is worthwhile to consider kicking the smoking habit, ... that cigarette smoking// enhances the risk of dying in middle ... reduces the risk of premature death. The study, which scores ... studies undertaken on this subject, that studies the habit of ...
... started, ads campaigning the need for Children to eat healthy ... day long//, but the mothers of many over weight children ... medical survey conducted by the government states that while 19 ... failed to accept it saying that they are similar to ...
... which all UK doctors must observe, the doctors must provide ... ethics and code of the Congregation for the Doctrine of ... cannot refer people for abortions - they can't say you ... the corner. ,With these codes as a base a ...
... not much to improve their standards, as stipulated by the Medical ... month deadline to comply with the norms or face a risk ... the power to accord affiliation to medical colleges across the country, ... due to end in May. ,A month has ...
... claimed two more lives, as informed by regulators who issued ... combination from the market. The drug combination, also called Mifeprex ... in any of those cases//. ,The Food and Drug ... infection previously implicated in four deaths of women who had ...
... Health Study of the Harvard School of Public Health in ... regular exercise// and concentrating on weight control. ,The ... had their body mass index (BMI) taken regularly. They were ... cycling and swimming. ,Women with a BMI between ...
Cached Medicine News:Health News:Catholic Church and Abortion. 2
Portable ultrasound doppler system for peripheral and transcranial investigation....
Bi-Directional doppler volume flowmeter....
One channel, one gate transcranial Doppler that is diagnosis oriented with an advanced protocol editor, automatic report generator and a powerful examination data base....
Locates flow easily, and identifies flow depth and direction for multiple vessels simultaneously....
Medicine Products: